Barry-Hundeyin Named KL2 Scholar
LEXINGTON, Ky. (Dec. 12, 2022) – The UK Center for Clinical and Translational Science has appointed Mautin Barry-Hundeyin, MD, PhD, assistant professor in the College of Medicine, Department of Surgery, Surgical Oncology, as its newest KL2 Career Development Scholar.
Barry-Hundeyin specializes in the management of hepatopancreatobiliary (HPB) and gastrointestinal (GI) malignancies. Her KL2 project is investigates macrophage regulation of peritoneal carcinomatosis in gastric adenocarcinoma, with the goal of discovering novel immunotherapeutics that make meaningful advancements in the care of cancer patients.
Her KL2 mentors on the project are Joseph Kim, MD, Ilhem Messaoudi, PhD, and Mark Evers, MD.
Dr. Barry-Hundeyin attended Pennsylvania State University College of Medicine where she was inducted into the Alpha Omega Alpha (AOA) Honor Medical Society. She completed her general surgery training at Harvard Medical School/Beth Israel Deaconess Medical Center, winning numerous teaching awards.
She subsequently completed a post-doctoral research fellowship at New York University, where she published landmark papers in pancreatic cancer tumor immunology. Most recently, she completed a fellowship in Complex General Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York.
Learn more about the CCTS KL2 Career Development Program.
Media Contact: Mallory Profeta, firstname.lastname@example.org